CsA Treatment. CsA, a gift from Sandoz, Co . Ltd ., Basel, Switzerland, was dissolved in olive oil (00) (Sigma Chemical Co ., St . Louis, MO) at a concentration of 5 mg/ml, then further diluted to the appropriate concentrations for intraperitoneal injection at a volume of 50 tel for newborn mice or 100 ul for adult mice .
Transplantation of Thymus into nu/nu Mice . Mice were anesthesized by Nenbutal and the kidney was exposed by retroperitoneal incision ; two thymic lobes from neonatally CsA-or 00-treated mice, or one lobe, cut into three to five pieces, from adult CsA-or 00-treated mice were engrafted under the renal capsule of bilateral kidneys with fine forceps .
ELISA for Detection of Autoantibodies . For detecting autoantibodies against the gastric parietal cells (PC), the microsome/plasma membrane fraction of gastric mucosa was prepared according to the method of Mariotti et al . (5) . Details of the method were described elsewhere (Sakaguchi, S ., and N . Sakaguchi, submitted for publication) . Briefly, the fundal portion of BALB/c mice stomachs was homogenized with an Ultraturax TP/ 18 homogenizer with 4 vol of 0 .25 M sucrose, centrifuged at 9,000 g for 30 min ; the supernatant was centrifuged again at 105,000 g for 60 min . The pellet was washed with PBS and solublized with 1 .0% Triton X-100 in 0 .01 M PBS . The solution was diluted 1 :1,000 with PBS (final protein concentration 25 Feg/ml) and used for overnight coating of 96-well ELISA plates (Flow Laboratories, Inc ., McLean, VA) . For detection of antithyroglobulin antibodies, ELISA plates were coated overnight with purified mouse thyroglobulins (2 kg/ml) . ELISA were performed according to the method of Voller et al . (6) . Briefly, the plates were incubated for 1 h at room temperature with the diluted test sera (twofold serial dilutions starting from 1 :10 dilution) ; after washing, they were incubated for 1 h with 1 Ag/ml of alkaline phosphatase-conjugated anti-mouse IgG (Sigma Chemical Co .) ; and the absorbance at 405 nm was measured by an ELISA reader (MR580 ; Dynatech Laboratories, Inc ., Alexandria, VA) after 30-min color development with 1 mg/ml of p-nitrophenyl disodium hexahydrate (Sigma Chemical Co .) in 10% diethanolamine buffer, pH 9 .8 . In this anti-PC autoantibody assay, the absorbance with the 1 :10 diluted sera from 3-4-mo-old normal BALB/c mice was 0 .07 ± 0 .028 (n = 50) . The titer of anti-PC autoantibody was, therefore, defined as the highest dilution at which the absorbance was >0 .1 . There was a good correlation between the titer and specificity of anti-PC antibodies assessed by indirect immunofluorescence (IF) tests with tissue sections and those by ELISA (Sakaguchi, N ., and S . Sakaguchi, manuscript in preparation) .
Other Methods. Tissue-specific autoantibodies were surveyed by indirect IF test with cryostat sections of normal mouse tissues, as previously described (2) . Histology was prepared by paraffin embedding and stained with hematoxylin and eosin .
Results and Discussion
Development of Autoimmune Disease in nu/nu Mice after Engrafting Thymus from CsA-Treated nu/-f-Mice. 6-wk-old female nu/nu mice were engrafted with either one thymus from 7-d-old female nu/-f mice treated daily with CsA (10 mg/kg body weight per day) for 1 wk from the day of birth, or one thymic lobe from the adult female nu/+ mice administered daily with CsA (20 mg/kg per day) for 2 wk . When examined histologically 3 mo later, some of the recipient nu/nu mice developed organ-specific autoimmune diseases, such as gastritis, oophoritis, thyroiditis, or insulitis whether CsA-treated donor mice were newborn or adult (Table 1) . Each autoimmune disease was accompanied by circulating autoantibodies specific for gastric parietal cells, oocytes (zona pellucida and/ or ooplasm), thyroglobulin, or cell surface of Langerhans' islet cells, respectively. Histological and serological characteristics of each autoimmune disease were similar to those produced in euthymic mice by neonatal CsA-treatment (Sakaguchi, S ., and N . Sakaguchi, submitted for publication) or those induced in nu/nu mice by the transfer of T cell subsets from nu/ -l-mice (2) (see refer- Fig. 1 for the titers of autoantibodies. " BALB/c nu/+ mice, newborn or adult (6 wk old), were inoculated daily with CsA (10 or 20 mg/kg body weight per day, respectively) or 00 from the day of birth (day 0) to day 6 or for 2 wk in adults . Thymus was removed the day after the last inoculation of CsA and transplanted under the kidney capsule of 6-wk-old female nu/nu mice . The recipient nu/nu mice were killed 3 mo later for examination of histology and check of autoantibodies . ence 2 for histology and autoantibodies demonstrable by indirect IF ; a manuscript is in preparation for pathology of insulitis and anti-islet cell autoantibodies) . Three nu/nu mice also developed mild systemic vasculitis (data not shown) . All nu/nu mice transplanted with the thymus showed elevated level of y-globulins (two to four times higher than the nontransplanted nu/nu mice). However, significant difference was not found between the groups transplanted with CsAtreated or 00-treated thymus in terms of serum IgG level, the autoantibody titer against single-stranded DNA, or spontaneous development of antibodies against non-self antigens, such as trinitrophenyl haptens (data not shown) . Table I . : Thymus obtained from 8-wk-old nu/+ mice treated with CsA (20 mg/kg body weight per day) for 2 wk was transplanted . ¢ Thymocyte suspensions (10") were intravenously inoculated at the time of thymus transplantation. a Thymocyte suspensions (10") were prepared from 8-wk-old nu/+ mice CsA treated for 2 wk .
for gastric parietal cells or oocytes in the thymus-engrafted nu/nu mice . Control nu/nu mice transplanted with the thymuses from 00-treated mice did not show histological evidence for autoimmune disease, but some mice developed a low titer of anti-PC autoantibodies (Fig. 1) . The mice with histologically evident gastritis or oophoritis generally showed high titer of anti-PC or anti-oocyte autoantibodies, respectively. Some of the recipients of CsA-treated thymus, however, developed high titer of anti-PC autoantibodies of IgG isotype, but little histological lesions. It is likely in these mice that helper T cells for autoantibody production were active, but the activity of effector T cells of cell-mediated immunity might be insufficient to elicit tissue damage, since our previous study (7) on similar organ-specific autoimmune disease induced by early neonatal thymectomy showed the definitive role of cell-mediated immune reactions in destruction of the target organs .
Inoculation of spleen cell suspensions from CsA-treated adult mice did not produce any histological or serological autoimmunity . Transfer of thymocyte cell suspensions from the CsA-treated adult mice, however, induced anti-PC autoantibodies (positive at dilution of 320-640 by ELISA), although histological lesions were not evident.
At the time of sacrifice, the transplanted thymuses were histologically populated with massive lymphocytes. The composition of thymocyte subsets was similar to that of a normal adult thymus . No significant difference was found in the number of peripheral Thy-1 + cells and the composition of T cell subsets between nu/nu mice transplanted with CsA or 00-treated thymus, i.e ., Thy-1 + cells, L3T4 + cells, and Lyt-2 + cells in the lymph nodes were,^-50,^-40, and -10%, respectively .
Prevention of Autoimmune Disease by Inoculation of Thymocytes. When thymocytes were inoculated immediately after transplantation of CsA-treated thymus, thymocyte suspensions (108) from normal nu/-I-mice could suppress the devel- Table I . I Thymus from the CsA-treated adult nu/+ mice (8 wk old) was transplanted in the right kidney, and the thymus from normal adult nu/-I-mice (8-10 wk old) was transplanted in the left kidney. § Thymus from the CsA-treated adult nu/-t-mice was transplanted in the right kidney, and normal nu/-1-thymus was transplanted in the left kidney 2 wk later.
opment of autoimmune disease, while those from CsA-treated nu/ + mice could not (Table II) . When the composition of thymocyte subsets was examined by two-color cytofluorometric analysis, L3T4 + , Lyt-2 -and L3T4 -,Lyt-2+ thymocytes were found to be absent from the thymus of CsA-treated mice (Sakaguchi, S ., and N . Sakaguchi, submitted for publication) . Thus, it is highly likely that however, transplantation of normal thymus 2 wk after engrafting CsA-treated thymus could not (Table III) . We suggested earlier (8) Table I . " Thymus obtained from 8-wk-old nu/-f-mice treated with CsA (20 mg/kg body weight per day) for 2 wk was transplanted . 4 Spleen cell suspensions (4 X 10 7) from 10-12-wk-old nu/+ mice were intravenously inoculated immediately after transplanting the thymus from the CsA-treated adult nu/-I-mice . I I Spleen cell suspension (4 X 10 7) from 1-3-d-old nu/+ mice were inoculated immediately after transplanting the thymus from CsA-treated adult nu/-/-mice .
could not prevent the disease. In the previous study, we demonstrated that CsA could deplete thymocytes irrespective of the age of mice . However, administration of CsA to euthymic mice caused organ-specific autoimmune diseases only when the drug was administered to newborns ; CsA treatment of adult mice failed to induce autoimmune disease even with higher doses of CsA and longer treatment periods (Sakaguchi, S., and N . Sakaguchi, submitted for publication) . These results taken together suggest the following: (a) normal thymus is continuously producing potential self-reactive (autoimmune) clones of T cells as well as suppressor T cells, the latter dominantly controlling the former ; (b) CsA can selectively abrogate the thymic production of such suppressor T cells in mice at any age, allowing unchecked production of self-reactive T cells through the thymus ; and (c) however, for self-reactive T cells to proliferate/differentiate into effector T cells of autoimmune disease, active suppressor T cells must be absent in the periphery or have not yet migrated to the periphery. Thus, engrafting of the thymus from CsA-treated mice into T cell-deficient nu/nu mice or CsA administration to euthymic newborn mice can cause autoimmune disease, but CsA administration to euthymic adult mice can not.
Summary
Organ-specific autoimmune diseases such as gastritis, oophoritis, thyroiditis, or insulitis developed in athymic nu/nu mice after engraftment of the thymus from euthymic nub + mice treated with cyclosporin A (CsA), a potent immunosuppressant. The development of autoimmune disease in the nu/nu mice was prevented by inoculation of thymocyte suspensions prepared from normal nub -F mice, but not by thymocyte suspensions from CsA-treated nub + mice . 
